October 17, 2017
…over the next year designed to develop personalized cancer vaccines—a breakthrough treatment that could help patients like their daughter fight the disease using their own immune system.
July 1, 2021
Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney.
September 26, 2022
Researchers study human milk, pregnancy and COVID-19. This story appeared in the Fall 2022 issue of UC San Diego Magazine.
April 22, 2021
…to receive their COVID-19 vaccine at the UC San Diego Health mobile vaccine clinic in City Heights. The Impact of COVID-19 on San Diego’s Refugee Community When COVID-19 officially became a pandemic in March 2020, the world and life as we knew it changed. Grocery store shelves emptied. Shelter-at-home orders…
August 4, 2021
“When will we get ‘back to normal?’” is a question looming on many Americans’ minds. The answer largely depends on the country’s ability to substantially ramp up immunity to SARS CoV-2.
September 8, 2021
Researchers found that breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as what has been previously reported in non-breastfeeding women, with no serious side effects in the breastfed infants.
October 15, 2020
…When Will a COVID-19 Vaccine Be Ready? UC San Diego’s fall plan continues to evolve, informed by the university’s Return to Learn program. We invited students, faculty and staff to submit their questions, including how UC San Diego is involved in COVID-19 vaccine development, when a vaccine may be approved,…
December 16, 2024
After dozens of clinical trials, there are still no effective vaccines against Staphylococcus aureus. In two new studies, scientists report that the pathogen turns on the protein interleukin 10, shutting down the protective vaccine response. But blocking the protein restores vaccine efficacy in an animal model.
December 2, 2013
…a safe and effective vaccine against this toxin. This “nanosponge vaccine” enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this…
April 19, 2013
…genetically engineered with a vaccine? That’s the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission. In a follow up study, they got their answer: Not yet, although the same method may…
